TORONTO, Aug. 1 /CNW/ - Transition Therapeutics Inc. ("Transition" or the
"Company") (NASDAQ:TTHI, TSX:TTH) reports today that there are no undisclosed
material changes or corporate developments involving the Company to account
for its recent change in stock price.
